Click Here to return To Results

 

Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia NEJM 376:2503-2506, Davis, M.C.,et al, 2017 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) dyskinesia,drug induced movement disorder movement disorder,drug induced movement disorder,extrapyramidal tardive dyskinesia tardive dyskinesia,treatment of treatment of neurologic disorder valbenzine

Click Here to return To Results